Toggle light / dark theme

European astronomers released the first images from the new Euclid space telescope last week.

The European Space Agency (ESA) and the U.S. space agency, NASA, designed Euclid to study dark matter and dark energy. Scientists think those hidden forms of matter and energy make up 95 percent of the universe.

ESA is leading the six-year mission with NASA as a partner. ESA said the images were the most detailed of their kind. They show the telescope’s ability to observe billions of galaxies up to 10 billion light years away.

Nephrologists — know the CTRX encephalopathy risk in ESRD patients. This case of a hemodialysis patient found blood and CSF concentrations 10 times usual — dose adjustment may be needed. Monitor for neuro changes when using CTRX in renal failure. pharmacology.


Ceftriaxone (CTRX) does not require dose adjustment based on the renal function status and is used to treat infections. Recently, several studies reported the incidence of antibiotic-associated encephalopathy due to CTRX in patients with end-stage renal disease (ESRD). We experienced a case of CTRX-related encephalopathy in a patient on hemodialysis. When CTRX-related encephalopathy was discovered, the CTRX concentrations were measured in the blood and cerebrospinal fluid (CSF). The highest blood and CSF CTRX concentrations in this patient were 967 and 100.7 μg/mL, respectively, which were approximately 10 times higher than the CSF concentrations in a previously evaluated patient with CTRX encephalopathy. The concentration of CTRX may be increased in patients with ESRD. Hence, encephalopathy must be suspected in this patient group when CTRX is used.

The wait time for a heart transplant is long — from many months to over a year. Some patients will never get the transplant they need.

But researchers may have come up with an artificial heart solution: a titanium, pumpless, device with spinning magnets — and it looks nothing like a bonafide heart.

The problem: Heart failure affects over six million people every year in the U.S., and treatment options are slim. Medication can help, but some people need a heart transplant for a full recovery. Still, donor hearts are hard to come by. The number of people who need a heart far exceeds what’s available. And, donor hearts aren’t one-size-fits-all. The blood type and size need to be just right.

Immigration to and living on Mars have long been depicted in science fiction. But before that dream turns into reality, there is a hurdle humans have to overcome—the lack of chemicals such as oxygen essential for long-term survival on the planet. However, the recent discovery of water activity on Mars is promising.

Scientists are now exploring the possibility of decomposing water to produce oxygen through electrochemical water oxidation driven by with the help of oxygen evolution reaction (OER) catalysts. The challenge is to find a way to synthesize these catalysts in situ using materials on Mars, instead of transporting them from the Earth, which is costly.

To tackle this problem, a team led by Prof. Luo Yi, Prof. Jiang Jun, and Prof. Shang Weiwei from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS), recently made it possible to synthesize and optimize OER catalysts automatically from Martian meteorites with their robotic artificial intelligence (AI)-.

Having healthy mitochondria, the organelles that produce energy in all our cells, usually portends a long healthy life whether in humans or in C. elegans, a tiny, short-lived nematode worm often used to study the aging process.

Researchers at the Buck Institute have identified a new drug-like molecule that keeps mitochondria healthy via mitophagy, a process that removes and recycles damaged mitochondria in multicellular organisms. The compound, dubbed MIC, is a that extended lifespan in C. elegans, ameliorated pathology in neurodegenerative disease models of C. elegans, and improved mitochondrial function in mouse muscle cells. Results are published in the November 13, 2023, edition of Nature Aging.

Defective mitophagy is implicated in many age-related diseases. It’s tied to neurodegenerative disorders such as Parkinson’s and Alzheimer’s; it plays a role in cardiovascular diseases including heart failure; it influences metabolic disorders including obesity and type 2 diabetes; it is implicated in muscle wasting and sarcopenia and has a complex relationship with cancer progression.